Introgen Therapeutics, Inc. (fka INGNQ)

[tchalla]

yeppers. the judge denied the creditors request to force a conversion to chapter 7. also they confirmed the plan which allows for equity holders to have an equal say on the liquidation trust plan and distribution. there are residual revenue streams in the confirmed plan, which allows for monies to be paid to class 4/equity interest holders/shareholders. this stock has value here imo of at least 10x current pps. very good play. evidently others from the outside have seen it too, as the stock looks like it has been being accumulated for over a couple of months now.